康泰生物(300601.SZ)：股东解除一致行动关系

Core Viewpoint - 康泰生物 has announced the termination of the concerted action agreement between its controlling shareholder, Du Weimin, and other parties, which will not affect the company's governance structure or ongoing operations [1][2] Group 1 - The termination of the concerted action agreement is set to take effect on February 6, 2026, and involves parties including Yuan Liping and Hangzhou Heikun Enterprise Management Co., Ltd. [1] - The termination will not lead to any changes in the controlling shareholder or actual controller of the company [2] - The parties involved will continue to comply with relevant laws and regulations regarding share reduction, and there will be no differences in commitments before and after the termination [2] Group 2 - The termination of the concerted action agreement is described as an optimization of corporate governance and is unrelated to any share reduction activities [2] - Yuan Liping and her associated entities will still need to adhere to the regulations set forth by the Shenzhen Stock Exchange regarding share reductions by controlling shareholders and actual controllers [2]